(RTTNews) - Amgen Inc. (AMGN) reported earnings for its third quarter that increased from the same period last year and beat the Street estimates. The company's bottom line came in at $2.83 ...
View upcoming earnings forecasts and in-depth analysis of company forecasts.
* The known adjustments are presented net of their related tax impact, which amount to approximately $2.39 per share. (a) The adjustments primarily include noncash amortization of intangible assets ...
THOUSAND OAKS, Calif., Oct. 25, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the fourth quarter of 2024. The ...
Baggy suits, baggy pants, baggy T-shirts—they're definitively cool, and it's time to start stocking up. Let your slim-cut T-shirts take a break for a little while, and don't be afraid of what an ...
Long-sleeved T-shirts are an underrated wardrobe staple. As stylist and fashion designer Jordan Page of @veryadvanced points out, the humble long-sleeved tee can look “classier than short ...
Amgen is posting strong growth across its diversified-medicines portfolio. A new weight-loss drug candidate could be a game-changer for the company. Trading at 17 times earnings, the stock offers ...
What do Amgen, Biogen, and Takeda have in common? Leaders of research and development at the three biopharma companies shared a stage Thursday at the STAT 2024 Summit in Boston and offered their ...
Fintel reports that on October 17, 2024, Bernstein initiated coverage of Amgen (LSE:0R0T) with a Outperform recommendation. What is the Fund Sentiment? There are 4,096 funds or institutions ...
An investor is suing Amgen Inc.'s leaders over the company’s $10.7 billion fight with the IRS, which has said the biopharmaceutical giant dodged a huge tax bill by shifting profits to a subsidiary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback